EP2902035
Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.10.2011EP published:
20.6.2018EP application number:
14004427.2
EPO information:
European Patent Register
Max expiry date:
13.10.2031
Title:
Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.
Timeline
Today
14.10.2011EP application
20.6.2018EP Publication
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
Inventor
Name:
Combette, Jean-MarcAddress:
Saint Cergues, FR
Name:
Deloche, CatherineAddress:
Genf, CH
Name:
Abadie, ClaireAddress:
Annecy, FR
Priority
Number:
PCT/EP2010/006284Date:
14.10.2010Country:
WO
Number:
PCT/EP2011/000307Date:
25.1.2011Country:
WO
Classification
Categories:
A61K 38/00, A61K 38/03, A61K 38/04, A61P 27/02